chr2-43949659-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_133259.4(LRPPRC):c.1678A>T(p.Ile560Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000752 in 1,612,744 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_133259.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRPPRC | NM_133259.4 | c.1678A>T | p.Ile560Leu | missense_variant, splice_region_variant | 16/38 | ENST00000260665.12 | NP_573566.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRPPRC | ENST00000260665.12 | c.1678A>T | p.Ile560Leu | missense_variant, splice_region_variant | 16/38 | 1 | NM_133259.4 | ENSP00000260665.7 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000685 AC: 172AN: 251056Hom.: 0 AF XY: 0.000693 AC XY: 94AN XY: 135648
GnomAD4 exome AF: 0.000771 AC: 1126AN: 1460454Hom.: 1 Cov.: 29 AF XY: 0.000775 AC XY: 563AN XY: 726614
GnomAD4 genome AF: 0.000565 AC: 86AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 20, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 560 of the LRPPRC protein (p.Ile560Leu). This variant is present in population databases (rs144826521, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of Leigh syndrome (PMID: 34440436). ClinVar contains an entry for this variant (Variation ID: 214587). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 15, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 01, 2022 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 16, 2020 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at